Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and ...
In an interview with Fox News' Sean Hannity, Health and Human Services Secretary Robert F. Kennedy Jr. made several ...
A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...
Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to HLX22 (AC101) ...
Achieved Q4 2024 PEMGARDAâ„¢ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 million; full-year 2024 net product revenue totaled $25.4 ...
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...
Batoclimab is an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED).
According to a new study, an experiment on monkeys has shown that Ebola can be cured with just a pill. First discovered in ...